G Herrera
Overview
Explore the profile of G Herrera including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
77
Citations
569
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Ezquerro P, Tomas R, Bejar-Pizarro M, Fernandez-Merodo J, Guardiola-Albert C, Staller A, et al.
Sci Total Environ
. 2019 Nov;
703:134757.
PMID: 31759706
Aquifer-systems have become a strategic source of fresh water in the present climatic conditions, especially under stress in arid regions like the Iberian Mediterranean Arc. Understanding the behavior of groundwater...
2.
Mery M, Orellana N, Acevedo C, Oyarzun S, Araneda F, Herrera G, et al.
Materials (Basel)
. 2018 Dec;
11(12).
PMID: 30567288
Nanoparticles can be used in a large variety of applications, including magnetic sensing, biological, superconductivity, tissue engineering, and other fields. In this study, we explore the fabrication of gas phase...
3.
Mellinger S, Dias D, Flores N, Palavecino A, Vigo G, Burgos D, et al.
Mult Scler Relat Disord
. 2018 Aug;
25:212-215.
PMID: 30107335
Introduction: Multiple Sclerosis (MS) is one of the leading causes of disability in young adults. Its prevalence varies according to different countries. In Argentina there is a wide heterogeneity regarding...
4.
5.
6.
Herrera G, Montoya N, Domenech-Carbo A, Alarcon J
Phys Chem Chem Phys
. 2013 Oct;
15(44):19312-21.
PMID: 24121534
The range of compositions and temperatures at which single-phase tetragonal and monoclinic Fe-containing zirconia nanoparticles are stable is reported. Both types of iron-doped zirconia particles were synthesized by annealing dried...
7.
Mills A, Antinori A, Clotet B, Fourie J, Herrera G, Hicks C, et al.
HIV Med
. 2013 Jan;
14(7):391-400.
PMID: 23298380
Objectives: The aim of the study was to compare the neuropsychiatric safety and tolerability of rilpivirine (TMC278) vs. efavirenz in a preplanned pooled analysis of data from the ECHO and...
8.
Prieto P, Kinsner-Ovaskainen A, Stanzel S, Albella B, Artursson P, Campillo N, et al.
Toxicol In Vitro
. 2012 Aug;
27(4):1357-76.
PMID: 22922246
ACuteTox is a project within the 6th European Framework Programme which had as one of its goals to develop, optimise and prevalidate a non-animal testing strategy for predicting human acute...
9.
Herrera G, Pardo V
Arch Pathol (Chic)
. 2010 Mar;
44(4):393-5.
PMID: 20270034
No abstract available.
10.
Richman A, Herrera G, Reynoso V, Mendez G, Zambrano L
Int J Immunogenet
. 2007 Nov;
34(6):475-8.
PMID: 18001306
The axolotl (Ambystoma mexicanum) has been characterized as immunodeficient, and the absence of major histocompatibility complex (MHC) class II polymorphism has been cited as a possible explanation. Here we present...